Immune Design Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Aug 02, 2017 20:02 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Aug. 02, 2017 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today reported financial results and a corporate update for the second quarter...
ESI Announces First Quarter Fiscal 2018 Results
Aug 02, 2017 20:02 pm UTC| Business
PORTLAND, Ore., Aug. 02, 2017 -- Electro Scientific Industries, Inc. (NASDAQ:ESIO), an innovator of laser-based manufacturing solutions for the microtechnology industry, today announced results for its fiscal 2018 first...
PacBio Announces New Agreement with Novogene to Purchase Ten Sequel Systems
Aug 02, 2017 20:02 pm UTC| Business
MENLO PARK, Calif. and SAN DIEGO, Aug. 02, 2017 -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) and Novogene Corporation today announced a new agreement by Novogene to purchase 10 Sequel® Systems, giving the...
Pacific Biosciences of California, Inc. Announces Second Quarter 2017 Financial Results
Aug 02, 2017 20:02 pm UTC| Business
MENLO PARK, Calif., Aug. 02, 2017 -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its second quarter ended June 30, 2017. Product, service and other revenue for the...
CommerceHub Announces Second Quarter 2017 Financial Results
Aug 02, 2017 20:02 pm UTC| Business
Revenue of $25.2 million increases 9%, $0.05 GAAP EPS, and $0.08 adjusted EPSSigns Top 10 U.S. Retailer and First U.K. Drop-Ship Retailer ALBANY, N.Y., Aug. 02, 2017 -- CommerceHub, Inc. (NASDAQ:CHUBA) (NASDAQ:CHUBK)...
Aug 02, 2017 20:02 pm UTC| Business
Tampa, FL, Aug. 02, 2017 -- MedHOK®, recognized by Inc. magazine and Deloitte as one of the fastest growing, most innovative healthcare SaaS companies, is proud to be the key financial supporter of the I /A\m Biking for...
Amdocs Limited Reports Third Quarter Fiscal 2017 Results
Aug 02, 2017 20:01 pm UTC| Business
Record Quarterly Revenue of $967M Expects Fiscal 2017 Revenue Growth of 3.5-4.5% YoY in Constant Currency Expects Fiscal 2017 Non-GAAP Diluted EPS Growth Outlook of 5.5-7.5% YoY Third Quarter Fiscal 2017 Highlights ...